eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
2/2023
vol. 10
 
Share:
Send email
Share:
abstract:
Review paper

The effectiveness of new antibiotics in the treatment of community-acquired pneumonia

Nikodem Trzcina
1
,
Joanna Wieczfińska
1
,
Rafał Pawliczak
1

  1. Zakład Immunopatologii, Oddział Nauk Biomedycznych, Wydział Lekarski, Uniwersytet Medyczny w Łodzi, Polska
Alergologia Polska – Polish Journal of Allergology 2023; 10, 2: 112–117
DOI: https://doi.org/10.5114/pja.2023.129082
Online publish date: 2023/06/30
View full text Get citation
 
PlumX metrics:
Community-acquired pneumonia (CAP), defined as acute pulmonary parenchymal infection acquired outside the hospital, remains one of the most common causes of hospitalization and death, especially among people over 65 and those with impaired immunity. This is a serious problem due to aging societies in many countries and comorbidities. Despite the development of diagnostic methods, in half of the patients with CAP, the etiology cannot be determined, which emphasizes the importance of empirical treatment and the risk of increasing antibiotic resistance to available preparations. In recent years, new antibiotics have been approved for the treatment of CAP, which may significantly improve the possibilities of empirical treatment of CAP.
keywords:

community-acquired pneumonia, antibiotics, lefamulin, delafloxacin, omadacycline, ceftobiprole


Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.